Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

2.

Quantitative, multiplexed detection of Salmonella and other pathogens by Luminex xMAP suspension array.

Dunbar SA, Jacobson JW.

Methods Mol Biol. 2007;394:1-19. doi: 10.1007/978-1-59745-512-1_1.

PMID:
18363228
3.

Direct visualization of cystic fibrosis transmembrane regulator mutations in the clinical laboratory setting.

Strom CM, Clark DD, Hantash FM, Rea L, Anderson B, Maul D, Huang D, Traul D, Chen Tubman C, Garcia R, Hess PP, Wang H, Crossley B, Woodruff E, Chen R, Killeen M, Sun W, Beer J, Avens H, Polisky B, Jenison RD.

Clin Chem. 2004 May;50(5):836-45.

4.

Detection of CFTR mutations using ARMS and low-density microarrays.

Eaker S, Johnson M, Jenkins J, Bauer M, Little S.

Biosens Bioelectron. 2005 Dec 15;21(6):933-9.

PMID:
15890513
5.

Cystic fibrosis mutation detection by hybridization to light-generated DNA probe arrays.

Cronin MT, Fucini RV, Kim SM, Masino RS, Wespi RM, Miyada CG.

Hum Mutat. 1996;7(3):244-55.

PMID:
8829658
6.

Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.

Feriotto G, Ferlini A, Ravani A, Calzolari E, Mischiati C, Bianchi N, Gambari R.

Hum Mutat. 2001;18(1):70-81.

PMID:
11438995
7.

Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.

Alibakhshi R, Kianishirazi R, Cassiman JJ, Zamani M, Cuppens H.

J Cyst Fibros. 2008 Mar;7(2):102-9.

8.

Fluorescence-based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations.

Eggerding FA, Iovannisci DM, Brinson E, Grossman P, Winn-Deen ES.

Hum Mutat. 1995;5(2):153-65.

PMID:
7538376
9.
10.
11.
12.

Microarray technology for mutation analysis of low-template DNA samples.

Salvado C, Cram D.

Methods Mol Med. 2007;132:153-73.

PMID:
17876083
13.

Cystic fibrosis carrier screening: validation of a novel method using BeadChip technology.

Edelmann L, Hashmi G, Song Y, Han Y, Kornreich R, Desnick RJ.

Genet Med. 2004 Sep-Oct;6(5):431-8.

PMID:
15371909
14.

A homogeneous method for genotyping with fluorescence polarization.

Gibson NJ, Gillard HL, Whitcombe D, Ferrie RM, Newton CR, Little S.

Clin Chem. 1997 Aug;43(8 Pt 1):1336-41.

15.

Detection of cystic fibrosis mutations by peptide mass signature genotyping.

Malehorn DE, Telmer CA, McEwen SB, An J, Kinsey AD, Retchless AC, Mason C, Vieta WM, Jarvik JW.

Clin Chem. 2003 Aug;49(8):1318-30.

16.

Screening unlabeled DNA targets with randomly ordered fiber-optic gene arrays.

Steemers FJ, Ferguson JA, Walt DR.

Nat Biotechnol. 2000 Jan;18(1):91-4.

PMID:
10625399
17.

Efficient 12-mutation testing in the CFTR gene: a general model for complex mutation analysis.

Shuber AP, Skoletsky J, Stern R, Handelin BL.

Hum Mol Genet. 1993 Feb;2(2):153-8.

PMID:
7684636
18.

Three novel CFTR polymorphic repeats improve segregation analysis for cystic fibrosis.

Elce A, Boccia A, Cardillo G, Giordano S, Tomaiuolo R, Paolella G, Castaldo G.

Clin Chem. 2009 Jul;55(7):1372-9. doi: 10.1373/clinchem.2008.119545.

19.
20.

Rapid detection of the ACMG/ACOG-recommended 23 CFTR disease-causing mutations using ion torrent semiconductor sequencing.

Elliott AM, Radecki J, Moghis B, Li X, Kammesheidt A.

J Biomol Tech. 2012 Apr;23(1):24-30. doi: 10.7171/jbt.12-2301-003.

Supplemental Content

Support Center